Clinical and endocrine studies in menopausal women after estradiol pellet implantation

M. Nagamani, T. J. Lin, P. G. Mcdonough, H. Watatanl, J. C. Mcpherson, V. Mahesh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Eight patients who required prolonged estrogen replacement therapy were implanted with two 25-mg pellets of estradiol-17β and were followed with serial measurements of serum estradiol, estrone, follicle stimulating hormone, luteinizing hormone, and maturation index of the vaginal smears. There was a significant increase in estrogen levels within 24 hours after pellet implantation, and this level was maintained in physiologic premenopausal range during the rest of the period of followup. Gonadotropins were suppressed to a greater degree in gonadal dysgenesis patients as compared to postmenopausal patients. There was rapid relief of vasomotor symptoms within 4-10 days even though the gonadotropin levels were high. Implantation of 50 mg of estradiol pellets and periodic withdrawal bleeding with a progestational agent seems to he an effective method of long-term replacement therapy.

Original languageEnglish (US)
Pages (from-to)541-547
Number of pages7
JournalObstetrics and Gynecology
Volume50
Issue number5
StatePublished - Jan 1 1977

Fingerprint

Estradiol
Gonadotropins
Gonadal Dysgenesis
Vaginal Smears
Estrogen Replacement Therapy
Estrone
Follicle Stimulating Hormone
Progestins
Luteinizing Hormone
Estrogens
Hemorrhage
Serum
Clinical Studies
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Nagamani, M., Lin, T. J., Mcdonough, P. G., Watatanl, H., Mcpherson, J. C., & Mahesh, V. (1977). Clinical and endocrine studies in menopausal women after estradiol pellet implantation. Obstetrics and Gynecology, 50(5), 541-547.

Clinical and endocrine studies in menopausal women after estradiol pellet implantation. / Nagamani, M.; Lin, T. J.; Mcdonough, P. G.; Watatanl, H.; Mcpherson, J. C.; Mahesh, V.

In: Obstetrics and Gynecology, Vol. 50, No. 5, 01.01.1977, p. 541-547.

Research output: Contribution to journalArticle

Nagamani, M, Lin, TJ, Mcdonough, PG, Watatanl, H, Mcpherson, JC & Mahesh, V 1977, 'Clinical and endocrine studies in menopausal women after estradiol pellet implantation', Obstetrics and Gynecology, vol. 50, no. 5, pp. 541-547.
Nagamani M, Lin TJ, Mcdonough PG, Watatanl H, Mcpherson JC, Mahesh V. Clinical and endocrine studies in menopausal women after estradiol pellet implantation. Obstetrics and Gynecology. 1977 Jan 1;50(5):541-547.
Nagamani, M. ; Lin, T. J. ; Mcdonough, P. G. ; Watatanl, H. ; Mcpherson, J. C. ; Mahesh, V. / Clinical and endocrine studies in menopausal women after estradiol pellet implantation. In: Obstetrics and Gynecology. 1977 ; Vol. 50, No. 5. pp. 541-547.
@article{941e97e79bae450cb0cfa21ba8fc60d4,
title = "Clinical and endocrine studies in menopausal women after estradiol pellet implantation",
abstract = "Eight patients who required prolonged estrogen replacement therapy were implanted with two 25-mg pellets of estradiol-17β and were followed with serial measurements of serum estradiol, estrone, follicle stimulating hormone, luteinizing hormone, and maturation index of the vaginal smears. There was a significant increase in estrogen levels within 24 hours after pellet implantation, and this level was maintained in physiologic premenopausal range during the rest of the period of followup. Gonadotropins were suppressed to a greater degree in gonadal dysgenesis patients as compared to postmenopausal patients. There was rapid relief of vasomotor symptoms within 4-10 days even though the gonadotropin levels were high. Implantation of 50 mg of estradiol pellets and periodic withdrawal bleeding with a progestational agent seems to he an effective method of long-term replacement therapy.",
author = "M. Nagamani and Lin, {T. J.} and Mcdonough, {P. G.} and H. Watatanl and Mcpherson, {J. C.} and V. Mahesh",
year = "1977",
month = "1",
day = "1",
language = "English (US)",
volume = "50",
pages = "541--547",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Clinical and endocrine studies in menopausal women after estradiol pellet implantation

AU - Nagamani, M.

AU - Lin, T. J.

AU - Mcdonough, P. G.

AU - Watatanl, H.

AU - Mcpherson, J. C.

AU - Mahesh, V.

PY - 1977/1/1

Y1 - 1977/1/1

N2 - Eight patients who required prolonged estrogen replacement therapy were implanted with two 25-mg pellets of estradiol-17β and were followed with serial measurements of serum estradiol, estrone, follicle stimulating hormone, luteinizing hormone, and maturation index of the vaginal smears. There was a significant increase in estrogen levels within 24 hours after pellet implantation, and this level was maintained in physiologic premenopausal range during the rest of the period of followup. Gonadotropins were suppressed to a greater degree in gonadal dysgenesis patients as compared to postmenopausal patients. There was rapid relief of vasomotor symptoms within 4-10 days even though the gonadotropin levels were high. Implantation of 50 mg of estradiol pellets and periodic withdrawal bleeding with a progestational agent seems to he an effective method of long-term replacement therapy.

AB - Eight patients who required prolonged estrogen replacement therapy were implanted with two 25-mg pellets of estradiol-17β and were followed with serial measurements of serum estradiol, estrone, follicle stimulating hormone, luteinizing hormone, and maturation index of the vaginal smears. There was a significant increase in estrogen levels within 24 hours after pellet implantation, and this level was maintained in physiologic premenopausal range during the rest of the period of followup. Gonadotropins were suppressed to a greater degree in gonadal dysgenesis patients as compared to postmenopausal patients. There was rapid relief of vasomotor symptoms within 4-10 days even though the gonadotropin levels were high. Implantation of 50 mg of estradiol pellets and periodic withdrawal bleeding with a progestational agent seems to he an effective method of long-term replacement therapy.

UR - http://www.scopus.com/inward/record.url?scp=0017729743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017729743&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 541

EP - 547

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -